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A major limitation of using synthetic scaffolds in tissue engineering is little 
growth of incorporated cells in the interior of the scaffold, resulting in insufficient 
angiogenesis in the scaffold interior. Recently, cells have been 3D bioprinted 
concurrently with biomaterials to produce a cellularized, bioactive, angiogenic 3D 
environment.  This thesis describes a novel solvent-extrusion method for printing 
polycaprolactone (PCL)/bioactive borate glass composite as a biomaterial for a cell-laden 
scaffold.       
 Bioactive borate glass was added to a mixture of PCL and organic solvent to 
make an extrudable paste, creating scaffolds measuring 10×10×1 mm3 in overall 
dimensions with pore sizes ranging from 100–300 μm. We compared depositing hydrogel 
droplets to depositing hydrogel filaments in between the PCL/borate glass composite 
filaments. Degradation of the composite scaffold with and without the presence of 
hydrogel was investigated by soaking the scaffold in cell culture medium. The weight 
loss of the scaffold together with formation of a hydroxyapatite-like layer on the surface 
shows the excellent bioactivity of the scaffold. This work demonstrates that incorporating 
borate glass to increase the angiogenic capacity of the fabricated scaffolds is feasible. We 
also compared cell survival and viability between the composite bio-ink to two 
commonly used hydrogels, Matrigel and Pluronic F127. The viability and proliferation of 
cells in the different biomaterials were analyzed with different methods demonstrating 
that cell viability was similar between the different bio-inks.  This 3D bioprinting method 
shows a high potential to create a bioactive, highly angiogenic 3D environment required 
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Bone defects, resulting from trauma, cancer, arthritis, infection, or congenital 
skeletal abnormalities, account for approximately 34 million surgeries per year.1 While 
autologous bone grafts achieve the best result, they create new defects and the possibility 
of increased morbidity in donors.2–6 Allografts can circumvent these issues, but they are 
troubled with limited availability, concerns over immunogenicity, and potential disease 
transmission.7  Engineered bone scaffolds are another treatment option but have not been 
as successful as autologous grafts due to insufficient vascularization and poor 
biomechanical function.8–10 
Additive manufacturing, also known as 3D bioprinting, is of particular interest in 
orthopedics due to the ability to print scaffolds with complex designs, controlled 
chemistry, and interconnected pores. 3D bioprinting is a process that fabricates a “living” 
construct in a layer-by-layer fashion using a “bio-ink” (cells suspended in a medium) 
with or without additional materials. The creation of a 3D environment with spatial 
arrangement of cells and materials is essential for vascularization and, therefore, 
complete implant integration with the surrounding tissue.  
3D bioprinting techniques can be broadly classified into four categories: (i) laser-
assisted,11,12 (ii) inkjet-based,13 (iii) stereolithography,10 and (iv) extrusion-based 
printing.14 In laser-assisted printing, energy generated by a laser pulse is used indirectly 
to create a droplet from a cell containing ribbon that is then deposited on a substrate.8,9 
The advantage of this process is being able to print relatively high viscosity biological 
materials with suspended cells. However, process precision and material properties 
required for shape control limits the availability of materials for this system. Inkjet 
printing produces fine droplets of cells suspended in media that can be deposited at high 
resolutions (~20 µm). However, the process can only utilize low-viscosity materials.6,7 
Stereolithography is a well-known and established technique in the 3D printing industry 
and works on the principle of selective photopolymerization using a light energy source 
on a reservoir containing materials and cells with a photo initiator. The resolution of the 




The last category of bioprinting, extrusion-based 3D bioprinting, allows the 
printing of cells, hydrogels, and other materials using one or multiple syringes and a 
pressure system. The pressure system consists of either a mechanical piston or a 
pneumatic pressure source (mostly compressed air) that is computer controlled. The 
material is extruded through a nozzle tip (industry standard) with orifice ranging from 
less than 100 µm to several hundred microns in diameter. The main advantage of 
extrusion based bioprinting is the wide range of materials that are compatible with the 
process, including high viscosity biopolymer pastes and hydrogels. The process can 
deposit hydrogels with different gelation mechanisms, with high cell density, and with 
minimal waste in comparison to laser assisted and stereolithography techniques. Overall, 
extrusion-based bioprinting is a very promising biofabrication method.15,16  
Synthetic materials, such as polycaprolactone (PCL), provide strength and 
elasticity to scaffolds. In addition, due to the high temperature required to melt other 
biopolymers such as polylactic acid (PLA, with a melting point of 160oC), PCL has 
become one of the most widely used biocompatible polymers owing to its low melting 
point of 60oC.17,18 For 3D printing, PCL is an attractive option because of its good 
rheological and viscoelastic properties. Despite its slow degradation rate (~2 years 
depending on the molecular weight), PCL has been widely used to fabricate scaffolds for 
bone tissue engineering.18–20 
Because pure polymer scaffolds fabricated using the melt-deposition process are 
only biocompatible and do not react in the body, another challenge is to make the 
scaffold bioactive. Bioactive glasses are biocompatible and resorbable, can be made into 
custom compositions and geometries, can be tailored to reliably degrade in minutes to 
years, and can be doped with most elements (i.e. copper).12 Additionally, most bioactive 
glasses form a hydroxyapatite (HA)-like layer, which is the precursor to bone, that bonds 
with both hard and soft tissue.9 Recently, silicate bioglasses – such as 45S5 – have been 
shown to be non-toxic to stem cells, serve as an excellent delivery vehicle for angiogenic 
factors and cells, and can contribute to stem cell differentiation into an osteogenic 
lineage.21,22 However, less is known about the effect of borate based bioglass 12-93B3. 
13-93B3 bioglass has a higher reaction rate (5-10 times faster than silicate glasses); is 
more resorbable (60 to 70% wt. loss) in a few days to weeks; and is angiogenic, 
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antimicrobial, and osteo stimulatory/conductive (Table 1.1).23–25 Despite these promising 
attributes, the use of borate based bioglass is limited due to the low strength and 




Table 1.1 Composition of 45S5 and 13-93B3 bioactive glasses.14  
Glass SiO2 B2O3 Na2O K2O MgO CaO P2O5 
In vivo Reaction 
rate (µm/wk) 
45S5 45.0 0 24.5 0 0 24.5 6.0 ~5-6 




Composite scaffolds can combine the benefits of multiple materials. By 
increasing the complexity of the scaffold with multiple materials and cells, matching both 
the biomechanical and biological properties of the target tissue becomes more 
feasible.15,16 In the past, researchers made polymer-bioactive glass scaffolds using fused 
deposition modeling (FDM).26 In FDM, the polymer is melted and deposited as filaments 
that solidify upon cooling in a layer-by-layer fashion. However, no significant 
improvement in bioactivity and cell growth was reported, which could be due to the 
inadequate ionic dissolution of the glass into the surrounding environment. This makes 
melt-deposition options unattractive for fabrication of polymer-glass composite scaffolds 
as they are less reactive when combined with bioactive materials. Therefore, it is 
essential to investigate alternate approaches for printing materials, such as solvent-based 
fabrication methods. 
 A variety of solvents are available to dissolve different biopolymers.27 Extrusion 
of solvent dissolved polymer and bioactive glass is safe at room temperature and reduces 
the process complexity since there is no need for temperature control. This method can be 
adopted by most of the existing open-source 3D printers available in the market. Previous 
studies have used chloroform (CF) to dissolve PCL for biomaterial applications.28 As a 
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solvent, CF provides: (i) a high viscosity paste, making it suitable for extrusion-based 3D 
printing, (ii) fast evaporation (~2 min), making it safe to print cells during the fabrication 
process, (iii) filament porosity for accelerated glass dissolution to the surrounding, and 
(iv) faster polymer bulk degradation by exposing the interior of filament.  
Another requirement to fabricate a “living” construct is cells. Mesenchymal stem / 
progenitor cells (MSCs) have been used for cell therapy and in tissue engineering 
because of their ability to differentiate into multiple mesenchymal lineages in vitro, 
immune modulatory effects, and angiogenic capacity.29,30 MSCs have been isolated from 
several tissues, including the bone marrow (BMSCs), adipose tissue (ASCs), and skin 
tissue.31–34 The frequency of MSCs in adipose tissue is much higher than the more 
commonly studied source of bone marrow, yielding 100 to 500 times more cells per 
tissue volume.35,36 ASCs have similar self-renewal abilities, common surface epitopes, 
growth kinetics, and cytokine expression profiles to BMSCs. ASCs are isolated from the 
stromal vascular fractions (SVF) of subcutaneous white adipose tissue.  A heterogenous 
cell population, SVF also includes blood cells, endothelial cells, adipocytes, 
macrophages, and various growth factors.37–40  
  In this series of studies, we (i) developed a novel composite scaffold wherein a 
polymer is dissolved in chloroform, mixed with borate bioactive glass, and then extruded 
to fabricate the scaffold, (ii) used this novel composite as a bio-ink for stem cells and 
compared cell survival to other commonly used bio-inks, (iii) compared different sources 
of stem cell populations from different species as bio-printing candidates, (iv) 
investigated the best scientific method to analyze stem cell activity after printing cells in 
different bio-inks. 
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2. MATERIALS AND METHODS 
 
2.1. CELL CULTURE 
 
2.1.1. Isolation of Rat Stromal Vascular Fraction.  Subcutaneous white  
adipose tissue was collected from 6-13 week old Sprague Dawley rats weighing 180-250 
grams. Approximately 3.5 grams of adipose tissue was collected per rat. Adipose tissue 
was washed in 50 mL of Hanks’ balanced salt solution (HBSS, Lonza, Walkersville, MD, 
USA) 2-3 times until the medium remained clear when shaken vigorously. To isolate the 
stromal vascular fraction (SVF), adipose tissue was minced with a razorblade and then 
incubated in a 0.1% (w/v) collagenase (from Clostridium histolyticum, Sigma-Aldrich, 
St. Louis, MO) HBSS solution in a 50 mL centrifuge tube at 37oC on a 5x G shaker 
(Innova 4000, New Brunswick Scientific, Edison, NJ)  for approximately 3 hours. During 
incubation, tissue was additionally shaken manually and vigorously for 5-10 seconds 
every 15 minutes. 
 After forming a “soup like” consistency, the collagenase was neutralized by 
adding an equal volume of D-10 cell culture media that consisted of 10% fetal bovine 
serum (FBS, Corning, Manassas, Virginia, USA), 1% 100x L-glutamine (GE Life 
Sciences, Logan, UT), 2% 100x antibiotic/antimycotic (GE Life Sciences, Logan, UT) 
and Dubelcco’s minimum essential media (DMEM, Sigma-Aldrich, St. Louis, MO). 
Digested tissue was filtered through a 100 μm mesh filter followed by a 70 μm mesh 
filter. The filtered cell solution was centrifuged at room temperature at 1000x g for 10 
minutes. The supernatant was aspirated, leaving the SVF pellet. 
2.1.2. Isolation of Rat Bone Marrow Derived Mesenchymal Stem Cells. 
Femurs were collected from 6-13 week old Sprague Dawley rats averaging 180-250 
grams. Within one hour of being sacrificed with carbon dioxide, femurs were removed, 
both distal ends of the femur were cut, and an 18 gauge needle was inserted into the shaft. 
Approximately 5 mLs of D-10 media was expelled into the femur to flush cells into a 25 
cm2 culture flask (TPP, Trasadingen, Switzerland). Flushing was repeated 3-5 times. 
After cells incubated overnight at 37oC with 5% CO2, they were then washed three times 
with 2 mL of pre-warmed phosphate buffered saline (PBS; Lonzo, Walkersville, MD). D-
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10 media was replaced every 3-4 days. When cells became 65-75% confluent, flasks 
were washed three times with 2 mL of pre-warmed PBS, harvested with 0.25% trypsin/ 
1mM EDTA, and passaged at 100 cells/ cm2. Passage 2-4 was used for all experiments. 
2.1.3. Cell Culture of Human Mesenchymal Stem Cells. Frozen vials of  
approximately 1x106 human ASCs (hASCs; LaCell, New Orleans, LA) or human BMSCs 
(hBMSCs; Texas A&M Institute for Regenerative Medicine, Temple, TX) were obtained 
from separate donors (Table 2.1). Vials were quickly unthawed in a water bath, plated on 
150 cm2  culture dishes in 25 mL complete culture media (CCM), and incubated at 37oC 
with 5% CO2 overnight. CCM contained 10% fetal bovine serum, 1% 100x L-glutamine, 
2% 100x antibiotic/antimycotic, and minimum essential medium alpha modified (α-
MEM, Sigma-Aldrich, St. Louis, MO). Cells were washed three times with 4 mL of pre-
warmed PBS, harvested with 0.25% trypsin/ 1mM EDTA, and passaged at 100 cells/cm2 
in CCM. Media was changed every 3 to 4 days. For all experiments, sub-confluent cells 




 Table 2.1 Demographic information for human MSCs. 
Cell Type Race Age Gender BMI 
hASC-1 Caucasian 40 F 24.37 
hASC-2 Caucasian 49 F 27.34 
hASC-3 Caucasion 28 F 24.65 




2.2. PREPARATION OF BIO-INKS  
 
2.2.1. PCL/13-93B3 Composite.  Polycaprolactone (Sigma- Aldrich, St. 
St. Louis, MO) was dissolved in chloroform (CF; Sigma-Aldrich, St. Louis, MO) in a 
covered glass container with the help of a stirrer at ~45°C. The PCL weight to CF volume 
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ratio (grams:mL) was varied from 1:1 to 5:4  to determine the ideal ratio for printing. An 
appropriate ratio was established by visually inspecting the paste and through filament 
extrusion using a digital syringe dispenser (Loctite®, Henkel North America, Rocky Hill, 
CT). Then, 13-93B3 glass (Mo-Sci Corporation, Rolla, MO) with ~20 µm particle size 
was added to the PCL:CF mix in five different weight percentages in increments of 10% 
ranging from 10% to 50%. A magnetic stir bar was used to uniformly mix the composite 
paste, and no settling of the glass particle precipitate was observed before transferring the 
paste to a syringe. Each ratio was tested using a digital syringe dispenser at air pressure 
ranging from 10 to 50 psi and with nozzle tip diameter ranging from 110 to 600 µm. 
2.2.2. Matrigel.  Matrigel (Corning, Bedford, MA) was thawed on ice for 3 
hours and diluted in DMEM to 9 mg/mL for droplets or to 4.5 mg/mL for filaments. For 
droplets, hASCs were suspended at a concentration of 10x106/mL of Matrigel. For 
filaments, 5x106 rBMSCs/mL or 5x106 rSVF/mL of Matrigel was used. Matrigel was 
gently mixed to obtain a uniform distribution of cells and transferred to a 160 µm nozzle 
tip. Matrigel incubated at 37oC for 5 minutes to crosslink before printing. 
2.2.3. Pluronic F-127 Hydrogel.  Pluronic F-127 hyrdogel (Pluronic; Sigma- 
Aldrich, St. Louis, MO) of 15% or 25% (w/v) was prepared using DMEM in a 50 mL 
glass beaker placed in an ice bath. The solution was mixed, covered, using a magnetic stir 
bar until Pluronic dissolved (about 30 minutes). The solution was allowed to sit for an 
hour at 4oC to remove bubbles formed during stirring. For filaments, 5x106 rBMSCs/mL 
or 5x106 rSVF/mL of Pluronic was used. Pluronic was gently mixed to obtain a uniform 
distribution of cells and transferred to a 160 µm nozzle tip. The Pluronic incubated at 
37oC for 5 minutes to crosslink before printing. 
 
2.3. SCAFFOLD FABRICATION 
 
 Scaffolds (10x10 mm2) were printed with 0-90o orientation of the filaments in alternate 
layers. Printing was performed with an assembled DIY 3D printer (Geeetech, Prusa I3 A 
Pro) that was modified to have two syringes connected to digital dispensers that were 
computer controlled (Figure 2.1). Scaffolds were printed either on a microscope slide 
(Thermo Fischer Scientific, Rochester, NY) or in a 12-well tissue culture plate (TPP, 
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Trasadingen, Switzerland). The printing parameters such as filament spacing, layer 
height, printing speed, etc. were identified based on visual inspection and optical 
microscopic images after a single layer extrusion. Printing parameters such as needle tip 
sizes and printing speed were uniform for all paste compositions after initial trials. 
Parameters such as air pressure and filament overlap were correspondingly modified for 









2.4. SCAFFOLD DEGRADATION  
 
Degradation of the PCL/13-93B3 composite was evaluated on 10x10x1 mm3 
scaffolds. Scaffolds were weighed and then placed in high density polyethylene (HDPE) 
bottles containing 300 mL of α-MEM per 1 g of scaffold for soaking, and incubated at 
37oC from 1-14 days. After incubation, scaffolds were removed, gently washed with 2 
mL of room temperature deionized (DI) water three times, and dried overnight. The dried 
scaffold was weighed to calculate the weight loss percentage. Each time interval had an 
n=3 and results were reported as mean ± standard deviation using a student t-test. 
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2.5. SCAFFOLD CHARACTERIZATION  
 
 Microscopic images were used to measure the filament width and pore size of the 
PCL/13-93B3 composite. Once fully dried, samples of the scaffold both just after printing 
and after the degradation study were sputter coated with gold/palladium (Au/Pd) for 60 
seconds. Scanning electron microscopy (SEM, Hitachi S-4700 FESEM, Hitachi Co., 
Tokyo, Japan) images were taken to evaluate the surface morphology of the scaffolds, 
internal structure of the filaments, and formation of hydroxyapatite-like material on the 
scaffold surface. Scans were run from 2θ values ranging from 10o to 80o using Cu Kα 
radiation (λ = 0.154056 nm) for X-ray diffraction (XRD) analysis (Philips X-Pert, 
Westborough, MA) on the as-received PCL, as-printed PCL/B3 glass scaffold, and the 
scaffold after α-MEM immersion to determine the changes in the crystalline/amorphous 
nature of the material. At least five measurements were taken of each scaffold; results 
were reported as mean ± standard deviation 
 
2.6. LIVE/DEAD ASSAY 
 
Printed cell-laded scaffolds incubated for 1 or 7 days in D-10 at 37oC with 5% 
CO2.  Cell numbers and viability was evaluated by a live/dead assay, per manufacturer’s 
protocol (Life Technologies, Eugene, OR).  In brief, scaffolds were removed from the 
incubator, washed three times in pre-warmed PBS, and incubated in live/dead stain for 15 
minutes at room temp.  Five images per scaffold were taken on a fluorescent microscope 
(Olympus IX51, Melville, NY), and images were quantified using Fiji software (NIH, 
Betheseda, MD).  Each time point had an n=3 and results were reported as mean ± 
standard deviation using a student t-test 
 
2.7. DNA QUANTIFICATION 
 
 Printed cell-laded scaffolds incubated for 1 or 7 days in D-10 at 37oC with 5% 
CO2.  DNA was quantified with CyQuant, per manufacturer’s protocol (Life 
Technologies, Eugene, OR).  In brief, scaffolds were removed from the incubator, 
washed three times in pre-warmed PBS, lifted with 0.25% trypsin/1mM EDTA, pelleted 
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in a 1.5 mL vial, and frozen at -80oC.  The pellet was incubated with CyQuant at room 
temperature for 5 minutes and fluorescence was measured at a wavelength of 480 nm 
using a microplate reader (FLUOstar Omega, BMG Labtech, Offenburg, Germany). The 
mean cell number ± standard deviation was calculated in excel with n=3 against a 
standard with a curve fit of R=0.99 and graphed. 
 
2.8. QUANTIFICATION OF CELL NUMBER 
 
 To determine the number of cells printed, droplets of bio-ink were printed on a 
microscope slide and immediately fixed in 10% paraformaldehyde (PFA; Affymetrix, 
Cleveland, OH). Droplets were stained with DAPI (Vector Laboratories, Burlingame, 
CA) and examined using a fluorescent microscope. The entire area of each droplet (n=4) 
was imaged and the approximate cell number was determined using Fiji software. 
  
2.9. METABOLIC QUANTIFICATION 
 
 Printed cell-laded scaffolds incubated for 1 or 7 days in D-10 at 37oC with 5% 
CO2. Scaffolds were then removed from the incubator, washed three times with PBS, 
lifted with 0.25% trypsin/1mM EDTA, and pelleted in a 1.5 mL vial.   
 Cells were re-suspended in 100 μL of D-10, transferred to a 96-well culture plate 
(TPP, Trasadingen, Switzerland) and cellular metabolic activity was measured with an 
MTT assay (Trevigen, Gaithersburg, MD) performed according to manufacturer’s 
protocol. Briefly, the MTT reagent was added, the plate incubated for 3 hours at 37oC, 
detergent was added, and the plate was left covered at room temperature overnight. 
Absorbance was measured at a wavelength of 570 nm using a microplate reader. Cell 
viability was calculated with n=3 using Excel and the mean absorbance ± standard 






3. RESULTS  
 
3.1. FABRICATION OF NOVEL PCL/13-93B3 GLASS SCAFFOLD 
 
3.1.1. Single Layer Tests.  The weight percentage of PCL was varied from 
1:1 to 5:4 (in grams of PCL to mL of chloroform) to determine the best ratio for 
fabricating the scaffold. During the initial set of tests, different compositions of paste 
were extruded using a hand-held syringe and with the help of a digital dispenser while 
varying the nozzle tip size and the air pressure. An air pressure between 30 and 50 psi 
provided uniform extrusion of the PCL+chloroform mixture. The ideal ratio of PCL and 
chloroform was determined to be 5 g of PCL to 3 mL of chloroform, extruded at 30 psi 
using a 260 µm (25G) nozzle tip. A larger tip size (>260 µm) would result in thick 
filaments which were not beneficial for achieving small pore size distribution in the 
scaffold. From there, 10 wt.% 13-93B3 glass was mixed with the PCL and chloroform 
and extruded using the printer from 3 to 10 mm/s. A reduced filament width (from 0.8 
mm to 1.8 mm) can be observed with increasing printing speed (Figure 3.1). The width of 





Figure 3.1 Single layer tests with C1 composite using different printing speeds (A) 







3.1.2. Two Layer Tests. The filament height and the spacing of the first layer 
were crucial parameters when printing successive layers. The filament height determined 
the height for each layer while the filament spacing defines how well the filaments bridge 
across the previous layer. The average height of filaments printed using a speed of 8 
mm/s was ~75 µm (Figure 3.2A). Therefore, a distance of 100 µm between the nozzle tip 
and substrate or previously deposited layer was used to fabricate subsequent scaffolds. 
The height of the filaments for 40 wt% and 50 wt% glass compositions remained the 
same if the same nozzle tip was used. The roundness of the filament improved with a 
smaller tip but because of the nozzle clogging issues, all the experiments were carried out 
with a 260 µm tip. Another important factor in this study is the dwell time between 
consecutive layers as this allows the chloroform to evaporate and allow the bottom layer 
to become more solid. A longer dwell time (>5 min) would warp the layer and a shorter 
dwell time (<1 min) is not sufficient for the layer to dry. The difficulty in bridging the 
second layer without dwell time can be noticed and was substantially improved with 1 
mm dwell time (Figure 3.2C). The ideal dwell time between layers was determined to be 





Figure 3.2 Determining layer height and dwell time on 10x10 mm2 scaffolds. 
(A) Cross-sectional view of the C3 filament measuring ~75 µm in height, (B) Second 
layer printing with zero dwell time, (C) Second layer printing with 1 min dwell time, and 







3.1.3. Multiple Layer Scaffolds. Based on the previous tests, scaffolds with  
multiple layers were fabricated using all five compositions (i.e. 10 wt.% to 50 wt.% 13-
93B3 glass). The minimum air pressure required to extrude the paste increased when 
glass content was increased from 10 wt.% to 30 wt.%. At higher glass content (40 wt.% 
and 50 wt.%), the nozzle clogged during fabrication. Therefore, additional chloroform 
(about 1 mL) was added to the paste to reduce the viscosity for clog-free extrusion using 
the 260 µm tip. The 13-93B3 glass weight percentage and PCL:Chloroform ratios used to 

















(g to mL) 
Final Printing Parameters 
(using C5 paste)  
C1 10 30 600-800 5:3 Printing speed – 8 mm/s 
C2 20 30 600-800 5:3 Dwell time – 2 min 
C3 30 40 600-800 5:3 Nozzle distance – 100 µm 
C4 40 30 700-800 5:4 Air pressure – 30 psi 




A filament width of 397±10 μm was measured for scaffolds printed with the C5 
paste while average pore size is dependent on the filament spacing. A filament spacing of 
600 µm provided square pores measuring ~160 µm (Figure 3.3A). In comparison, the 
average pore size was ~350 µm for scaffolds with 800 µm filament spacing while in 
scaffolds with a spacing 700 µm, the pore size varied from ~200 to ~300 μm. Therefore, 
pore sizes could be adjusted by modifying the filament spacing, to a certain extent, to suit 






Figure 3.3 Micro- and macroscopic images of PCL/13-93B3 composite scaffolds. 
(A) Optical microscopic image showing the pores (~160 µm) in a composite scaffold 
fabricated with C5 paste. (B) Scaffolds fabricated with different composite pastes (C1 to 
C5); warpage shown with an arrow indicating space between scaffold and slide. Warpage 
was minimal in C3/C4 scaffolds and completely absent in C5 scaffolds. (C) Cross section 




It should be noted that the maximum thickness (or height) of the scaffolds 
depends on the degree of chloroform evaporation and the distance between layers. All the 
experiments were carried out at room temperature (64°F) where the variation in relative 
humidity (58-60%) was not considered to be a major factor. Faster chloroform 
evaporation would produce warpage of the fabricated scaffold, especially with some 
dwell time between the layers. Non-uniform distribution of the PCL and glass is not 
believed to be one of the major factors of warpage as, upon examination of the filaments’ 
microstructure when printed with the same syringe at different time intervals, there was 
similar and uniform deposition of glass particles throughout the matrix. Therefore, the 
chloroform evaporation and the percentage of PCL in the composite are two of the crucial 
factors that determine the warpage. Increasing the glass content in the composite would 
indirectly decrease the chloroform content and thereby aids in faster evaporation and 
improves the filament rigidity. Warping was predominant with C1 and C2 pastes while 
fabricating scaffolds using an 800 µm filament spacing and this led to difficulty in 
printing after about 8 layers (640 µm) (Figure 3.3B). The warpage in scaffolds fabricated 
with C3 paste was less pronounced and a scaffold height of 800 µm (10 layers) was 
obtained. Overall, the best results were achieved for scaffolds fabricated with C5 paste as 
they were successfully printed to 1 mm height (12 layers). The scaffolds fabricated with 
C5 paste had enough strength to be safely handled for subsequent degradation and in 
vitro assessment. The scaffolds fabricated with the C3-C5 pastes were reproducible to the 
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extent that 3 out of 4 scaffolds were consistent in quality. However, even with the C5 
paste, there was insufficient bridging between the filaments, resulting in a mesh with 
pores only in one direction rather than a porous scaffold (Figure 3.3C). 
 
3.2. MICROSCTRUCTURE EVALUATION OF PCL/13-93B3 COMPOSITE 
SCAFFOLD 
 
 Scanning electron micrographs of composite scaffolds made with C4 and C5 
composites showed the surface morphology of the filament (Figure 3.4). Glass particles 
are conspicuously absent from the surface of the scaffold filaments (Figure 3.4A-C). No 
pores on the filament surface were detected even when observed at a 2000x 
magnification (Figure 3.4C). Glass particles dispersed in the PCL matrix can be seen in 
the interior when examining the cross-sectional surface of the filament (Figure 3.4D-F). 
The dissolved PCL in chloroform encloses the glass particles and surface tension effects 
between the nozzle tip and PCL during extrusion appear to have caused the presence of 





Figure 3.4 SEM images of the C5 PCL/13-93B3 glass scaffold. 
(A) Low magnification (30x) and (B) Medium magnification (90x) images of scaffold 
surface showing filaments and pores, (C) Smooth surface morphology of filament (2000x 
magnified image), (D) Fractured surface of a broken filament with PCL matrix and glass 
particles, (E-F) Magnified image of the fracture surface in (D). 
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3.3. DEGRADATION AND BIOACTIVITY OF PCL/13-93B3 COMPOSITE 
SCAFFOLD 
 
 The degradation of the composite was evaluated by soaking the scaffolds in α-
MEM for 1, 3, 7, and 14 days. The scaffold weight before and after immersion (post 
drying) was recorded at each time interval. No significant weight loss was observed for 3 
days (less than 1%), and the measured weight loss was 10.7±5% at 7 days and 23.2±4% 
at 14 days. As PCL takes a longer time to degrade, the weight loss measured is most 
likely due to the ionic dissolution of the 13-93B3 borate glass.  
 Formation of flower like florets, which typically represent HA-like material, was 
observed on the filament surface (Figure 3.5A and 3.5B). Fine cracks on the filament 
surface which are a couple of microns wide and up to ten microns or more in length can 





Figure 3.5 SEM images of a C5 glass scaffold after 14 day immersion in α-MEM at 37oC. 
(A) ~1 µm thick layer was formed on the filament surface (a piece of the reacted layer 
indicated by arrow raised to expose the polymer beneath), (B) magnified image (8000x) 
of the area marked in (A) showing the formation of HA-like florets on the filament. (C) 
Surface cracks on the filament indicated by arrows in (i) and (ii). Pores inside the 
filament measuring less than 10 µm are indicated by arrows in (iii). 
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The degradation results also show a controlled release of 13-93B3 glass over a 
period of two weeks into the surrounding solution (Figure 3.6). In the past, composite 
thin films have been made using PCL/13-93B3 glass and PCL/45S5 glass with different 
amount of glass content28. The degradation data of such thin films indicate that the entire 
glass almost completely dissolves in about three days. The graph shown Figure 3.6 
compares the weight loss percentage of the PCL/13-93B3 glass thin films (80 µm) with 
that of the current study. Almost all the 13-93B3 glass was reacted in about 3 days from 
thin films. The faster degradation in composite films could be due to the small thickness 
of the film. The scaffolds in the current study are made by filaments which are about 400 
µm in diameter and have no surface pores, which explains the very little glass dissolution 
in three days. However, the water absorbing potential of polymers in general was 
reportedly found to improve after the addition of bioceramic filler materials such as HA 





Figure 3.6 Weight loss comparison of 3D printed C5 scaffolds vs. thin film composites.28 





In this study, the glass dissolution increased significantly after 7 and 14 days, 
which is believed to be due to the internal porosity of the filament created after the CF 
evaporation and glass dissolution creating more porosity. The B2O3 present in the borate 
glass (Table 1.1) completely dissolves into the surrounding environment, and the 
remaining oxides with the exception of MgO participate in the formation of HA. By 
neglecting the weight of HA formed, it can be theoretically calculated that there is about 
~35% weight loss for the scaffold, assuming a complete 13-93B3 glass dissolution in 
50:50 PCL/13-93B3 composite. In this study, the weight loss for 50:50 PCL/13-93B3 
composite scaffold was ~23%, indicating that ~70% of the 13-93B3 glass present in the 
scaffold had reacted in 14 days. This degradation vs. time characteristic can be used to 
develop a controlled degradation of 3D scaffold by adjusting the filament thickness that 
is beneficial in certain tissue engineering applications, especially in drug delivery. 
The energy-dispersive X-ray spectroscopy (EDX) analysis indicated the presence 
of calcium (Ca), phosphorous (P), and oxygen (O) on the reacted surface of the scaffold 
after 14-day immersion in α-MEM (Figure 3.7A) by detecting changes in elemental 
composition in atomic weight percent along a line. The location of the scan was selected 
such that a scan line (~70 µm long) had to start on a reacted surface, pass through the 
exposed PCL surface, and end on the reacted surface (Figure 3.7B). All the signals from 
the EDX analysis correspond to K series emissions (Kα and Kβ). It can be observed that 
the percentage of Ca and P drops to zero along with a decrease in O when scanning the 
PCL surface (from ~30 µm to ~50 µm in Figure 3.7A). The presence of Ca, P, and O 
indicates that the glass has reacted and formed a material with a similar profile to HA on 







Figure 3.7 EDX analysis on the surface of the C5 scaffold soaked in α-MEM. 
(A) Graph of line scan data showing the variation in Ca, P, O, and C in atomic weight 
percentages; presence of Ca, P, and O on the reacted surface confirms the glass 
reaction and formation of HA-like material, (B) SEM image with the arrow line 




The reacted layer formed on the scaffold surface was ~1 µm thick and not 
completely uniform (dense collection of florets can be seen in Figure 3.5B). XRD 
analysis was performed to confirm the presence of crystalline HA but the XRD pattern 
obtained on a 14 day soaked scaffold could not match the known HA crystalline peak. 
This is believed to be due to the formation of amorphous HA or non-stoichiometric HA, 
which is not uncommon in such cases. XRD patterns of the as-received 13-93B3 glass, 
PCL/13-93B3 glass composite scaffold, and the composite scaffold after soaking in α-
MEM for 2 weeks were obtained (Figure 3.8). The semi-crystalline nature of the PCL 
was confirmed with characteristic peaks (marked by *) and amorphous profile of 13-
93B3 glass with no sharp peaks and characteristic hump can be observed in the XRD 
patterns (Figure 3.8). There are additional peaks observed for the α-MEM soaked sample 
which could not be identified to a known material in the database (marked by †) that is 
most likely non-stoichiometric HA. However, the typical amorphous hump seen in glass 
was not existent in the soaked sample, indicating that most of the 13-93B3 glass in the 






Figure 3.8 XRD patterns comparing different aspects of C5 scaffolds. 
(A) 50:50 PCL/13-93B3 glass composite scaffold soaked in α-MEM for 14 days, (B) 
PCL/13-93B3 glass scaffold as printed, (C) as-received PCL showing a semi-crystalline 
nature with characteristic peaks marked by *, and (D) as-received 13-93B3 glass with 




3.4. COMPARISON WITH 45S5 
 
Due to the mesh structure seen when using the 13-93B3 glass, a comparison was 
made using the silicate based 45S5 glass. The printing parameters in Table 3.1 were 
found to be compatible for a PCL/45S5 composite (Figure 3.9) as well. The average pore 
size for all compositions was ~360 µm with a filament spacing of 800 µm (Figure 3.9A), 
similar to the 13-93B3 composite (Figure 3.3A). A common feature of both the 13-93B3 
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and the 45S5 composite is the filaments filling in the pore space rather than bridging 
them. In both cases, the result is a mesh structure with pores only in the z-direction rather 
than a true scaffold (Figure 3.3C and 3.9C). This indicated that the mesh structure was a 





Figure 3.9 Micro- and macroscopic images of PCL/45S5 composite scaffolds. 
(A) Optical microscopic image showing the pores (~160 µm) in a composite scaffold 
fabricated with C5 paste. (B) Scaffolds fabricated with different composite pastes 




3.5. PRINTING STEM CELLS IN MATRIGEL 
 
3.5.1. Matrigel Droplets. Initially, experiments were conducted to print droplets  
of hASCs suspended in DMEM. It was determined that a 110 µm (32G) nozzle tip 
extruded droplets less than 500 µm, which was suitable for printing either on top or 
alongside the deposited PCL/glass filaments, allowing the printing of the Matrigel to not 
interfere with the printing of the composite. However, DMEM droplets evaporated too 
quickly, drying out the cells. Therefore, the option of using a hydrogel, Matrigel, as a 
medium to suspend the hASCs was examined. The initial set of experiments included 
dispensing the Matrigel droplets without cells with the syringe dispensing system set-up 
to determine an appropriate concentration of Matrigel in DMEM and droplet size. A 
concentration of 10mg/mL Matrigel provided smaller drops (~100 µm), while 8 mg/mL 
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Matrigel produced larger drops (~500 µm), and 4 mg/mL Matrigel produced even larger 
drops (1 mm) (Figure 3.10). 
 




 In each case, Matrigel provided a stable environment for the cells without drying 
(measured for up to 10 minutes) with longer times when printed closely together as 
would be in a scaffold. As the filament width of the scaffolds was measured between 400 
to 500 µm, a Matrigel concentration of 9 mg/mL was selected to be appropriate for 
generating droplets which could be deposited on top of the filaments. Approximately 
1x106 cells suspended in PBS were pipetted in Matrigel. Immediately before printing, the 
hASCs+Matrigel bio-ink was transferred to a 160 µm nozzle tip that had been kept on 
ice.  
The ideal parameters for dispensing hASCs+Matrigel bio-ink droplets were 
investigated. Parameters including distance of the nozzle tip from glass slide, dispensing 







Table 3.2 Experimental set-up to determine hASC + Matrigel printing parameters. 




Air Pressure  
(psi) 
100 25 10 
200 25 10 
100 35 10 
200 35 10 
100 25 20 
200 25 20 
100 35 20 




Droplets made at higher air pressure (20 psi) only showed the presence of cells in 
a blue ring (Figure 3.11E-H) indicating that cells are at the boundary of the droplet due to 
the high pressure irrespective of the other two parameters. Droplets printed at the lower 
air pressure (10 psi) provide a more uniform distribution of cells, the presence of which 
are indicated with white arrows (Figure 3.11A-D). An even distribution of cells is ideal 
when printing to ensure better coverage of the scaffold.  
 Droplets printed with 10 psi and a height of 200 µm from the substrate had more 
cells (152±1) in comparison to those printed at 10 psi with a height of 100 µm (127±20). 
When comparing the pulse time, the droplets printed using 35 ms had a slightly higher 
cell count than those printed using 25 ms by 3 cells on average. Therefore, the printing 
parameters for Matrigel droplets were determined to be: (i) air pressure of 10 psi, (ii) 
distance from glass slide of 200 µm, and (iii) pulse duration of 35 ms. These parameters 






Figure 3.11 DAPI stained fluorescent images of 1x106 hASCs/mL Matrigel 
printed at (A-D) 10 psi and (E-H) 20 psi. (A,E) A pulse time of 35 ms and 200 µm 
distance from glass slide (B,F) 25 ms and 200 µm (C,G) 35 m s and 100 µm (D,H) 25 ms 
and 100 µm. The average number of cells at 10 psi is 127 while the average number at 20 







3.5.2. Viability of Stem Cells Printed on Composite Scaffold. The viability 
of hASCs printed at 10 psi on three layers of the C5 composite was studied by 
performing a live/dead assay after incubating the samples for 24 hours and 1 week. This 
was to address the safety issue of using CF while depositing hASCS. The viability of 
cells after 24 hours was 70±10% (Figure 3.12A and 3.12B) as calculated from 15 
representative images of 3 scaffolds. After 1 week, the viability of cells was 58±11% 
(Figure 3.12C and 3.12D). The cells and the Matrigel appear to be adhering to the 





Figure 3.12 Representative Live/Dead images of Matrigel encapsulated ASCs on C5 
scaffold. Imaged after (A-B) 24 hours with 70% viability, and (C-D) 1 week with 58% 




3.5.3. Matrigel Droplets in Multiple Layer Scaffolds. After printing three  
layers of the PCL/13-93B3 composite (240 μm thick) with a single layer of Matrigel 
droplets, the efficacy of this methods with multiple layer scaffolds was investigated. 
Therefore, 10 layer PCL/13-93B3 scaffolds (800 μm thick) were printed without any 
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Matrigel and compared to scaffolds with 5 layers of Matrigel droplets printed every two 
layers (Figure 3.13). The scaffolds could not be printed any thicker due to material build 
up on the edges causing bridging of the pores.  Additionally, some of the scaffolds (about 





Figure 3.13 C3 scaffolds printed (A) without and (B-C) with Matrigel. 
(D) Side view of (C) showing warping. Scaffolds are 10x10 mm2 and 10 layers (800 μm 
thick). The scaffold in (A) contains no Matrigel while the scaffolds in (B-C) contain 5 




 Because the droplets affected the printing of the scaffold, it was decided that 
further tests would use hydrogel filaments printed between the composite filaments rather 
than hydrogel droplets (Figure 3.14). The placement of the droplets was not precise 
enough using the current printer to avoid impeding deposition of the following composite 
layers over time. In addition, printing hydrogel filaments between the composite 











3.6. COMPARE PCL/13-93B3 COMPOSITE TO OTHER BIO-INKS 
 
3.6.1. Without Cells.  Single layers were printed for each bio-ink. Parameters 
for the C3 composite filaments were determined in the previous section. PBS, used as a 
control to measure cell death through the printing process, had a large amount of 
spreading when printed even with a 60 µm nozzle and only 2 psi (Figure 3.15A). 
Increasing the printing speed from 10 mm/s did not produce more consistent filament size 
and shape. Pluronic (15% w/v) and Matrigel filaments (4.5 mg/mL) had similar 
properties. Both required a 160 µm nozzle and were printed at 2 psi and 10 mm/s (Figure 
3.15B and 3.15C). Any larger nozzle or higher pressure and the hydrogel spread such that 
there was no longer space between the printed filaments and instead there was just a 
puddle. A smaller nozzle (<160 μm) and decreased pressure (<2 psi) did not print 
consistently and produced filaments that were not continuous. A filament spacing of 1 
mm was required for the PBS, Matrigel, and Pluronic to prevent the filaments 







Figure 3.15 Macroscopic images of (A) PBS, (B) Matrigel, (C) Pluronic, and (D) C3 





3.6.2. With Cells. Approximately 5x106 rBMSCs/mL were suspended in C3 
paste, Matrigel, Pluronic, and PBS. One layer was printed of each bio-ink and they were 
incubated in cell culture conditions for 1 day and 1 week.  The majority of the rBMSCs in 
the pluronic and Matrigel are noticeably suspended after one day while after 1 week there 
is a mix of suspended rBMSCs and adhered rBMSCs exhibiting a fibroblast-like 
morphology integral to MSCs (Figure 3.16B and 3.16C). Using bright field microscopy, 
no cells can be observed in the composite as the filaments were too dense to image 
through properly (Figure 3.16D). 
 Upon examination using a Live/Dead stain and fluorescent microscopy, the 
composite shows signs of cell survival within the filament both one day and one week 
after printing with rBMSCs (Figure 3.17). With Matrigel and Pluronic, the cells are 
mostly in clusters and remain in the filaments in which they were printed after one day 
Figure 3.17B and 3.17C). After a week, the cells in Matrigel and Pluronic started to 
spread and adhere to the plate, though some remained suspended (Figure 3.17F and 
3.17G). The rBMSCs printed with the PBS show an increased amount of death along the 
edges of where they were printed both one day and one week after printing (Figure 3.17A 
and 3.17E). There was no statistical difference between the viability of the cells of each 
bio-ink both one day and one week after printing indicating no long term negative effects 





Figure 3.16 Bright field images of rBMSCs after (A,C,E,G) 1 day and (B,D,F,H) 1 week 
suspended in (A-B) PBS, (C-D) Matrigel (4.5 mg/mL), (E-F) Pluronic (15% w/v), and 
(G-H) C3 composite. The cells were printed at a concentration of 5x106 per mL. Scale 








Figure 3.17 Viability of rBMSCs (A-D,I) 1 day and (E-H,J) 1 week after printing 
suspended in (A,E) PBS, (B,F) Matrigel, (C,G) Pluronic, and (D,H) the C3 composite. 
No statistical difference in viability between the different bio-inks both (I) 1 day and (J) 1 
week after printing. The rBMSCs were suspended at a concentration of 5x106 cells per 




3.7. COMPARISON OF DIFFERENT STEM CELL POPULATIONS  
 
3.7.1. Rat SVF. The concentration of cells per mL of bio-ink was investigated  
using 25% w/v Pluronic with rSVF and rBMSCs. A single layer of Pluronic was printed 
in a 10x10 mm2 scaffold. After one day, a live/dead stain shows ~95% cell death for the 
rSVF at all concentrations (Figure 3.18A-C). It was also noticed that the Pluronic did not 
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remain in distinct filaments after the media was added. Most likely, this was due to the 
media being too cold when added, causing the Pluronic to dissolute. A high degree of cell 
death is expected with SVF as it contains many different cell types and the culture media 
(D-10) is specific just to MSCs. Therefore, the experiment was repeated with rBMSCs 
with 5x106 and 10x106 cells. However, once again there was about 96% cell death after 
one day (Figure 3.18D-E). The large amount of cell death after one day using both rSVF 





Figure 3.18 Live/Dead images of cells suspended in 25% w/v Pluonic at 
(A) 5x106, (B) 10x106, and (C) 20x106 rSVF per mL and (D) 5x106 and (E) 10x106 
rBMSCs per mL. The images are the (i) live cells, (ii) dead cells, and (iii) a combined 





 Despite the problems encountered using rSVF previously, the positive results 
from different bio-inks using rBMSCs prompted a trial with rSVF. Approximately 5x106 
rSVF/mL of bio-ink was suspended in PBS, Matrigel (4.5 mg/mL), Pluronic (15% w/v) 
and the C3 composite. One layer of each bio-ink was printed and scaffolds were 
incubated in cell culture conditions for one day. The results show a distinct lack of cells 
via both bright field and fluorescent imaging (Figure 3.19). A large amount of cell death 
is expected within the first 24 hours for SVF due to the variety of cell types and the 
culture media being optimized for only MSCs. Therefore, it was concluded that a 





Figure 3.19 (A,C,E,G) Bright field and (B,D,F,H) live/dead images one day after printing 
rSVF suspended in (A-B) PBS, (C-D) Matrigel (4.5 mg/mL), (E-F) Pluronic (15% w/v), 
and (G-H) C3 composite. The cells were printed at a concentration of 5x106 per mL and 
had <5% viability for all bio-inks. The images are the (i) live cells, (ii) dead cells, and 
(iii) a combined image of live and dead cells. The scale bars on the bright field images 
are 1 mm while the fluorescent images are 250 µm. 
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3.7.2. Human Cells. A mixture of 5x106 hASCs and hBMSCs was suspended  
in the different bio-inks, printed, and analyzed after one day using a live/dead stain and 
bright field microscopy (Figure 3.20). Matrigel (4.5 mg/mL) and Pluronic (15% w/v) 
both had a mixture of cells staying suspended in the hydrogel as well as cells showing a 
fibroblast-like morphology (Figure 3.20B and 3.20C). The cells printed in Pluronic are 
similar to the PBS control in that they started showing directional growth (Figure 3.20A 
and 3.20C). The composite shows signs of cell survival within the filaments as well 





Figure 3.20 (A,C,E,G) Bright field and (B,D,F,H) live/dead images one day after printing  
hASCs and hBMSCs suspended in (A,B) PBS, (C,D) Matrigel (4.5 mg/mL), (E,F) 
Pluronic (15% w/v), and (G,H) C3 composite. The cells were printed at a concentration 
of 5x106 per mL. The images are the (i) live cells, (ii) dead cells, and (iii) a combined 
image of live and dead cells. The scale bars on the bright field images are 1 mm while the 
fluorescent images are 250 µm. 
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3.7.3. Viability. The viability of the different stem cell populations was 
compared after one day for all bio-inks. A low viability was seen for all cell types and 
concentrations in the 25% w/v Pluronic while there was low and inconsistent viability of 
the rSVF in all bio-inks (Figure 3.21). For all bio-inks, the rBMSCs had an average  
viability of 60% or higher while the hMSCs had an average viability of 80% or higher.  
However, the only difference between the two statistically is with the 15% w/v Pluronic. 
From this data, it was concluded that the 25% w/v Pluronic provided unsuitable tissue  
culture conditions, the viability of rSVF cannot be evaluated after one day, and there is 
no statistical difference in viability for PBS, Matrigel, 15% w/v Pluronic, and the 
composite. 
 
3.8. INVESTIGATING THE BEST METHOD TO ANALYZE STEM CELL 
ACTIVITY AFTER PRINTING CELLS IN DIFFERENT BIO-INKS 
 
After both one day and one week, it can be determined that CyQuant is not a viable 
option to estimate cell number for the composite (Figure 3.22C-D). Approximately 4.5-
7x104 cells were printed per scaffold and almost no cells were measured in the composite 
after one day. After one day, the assay detected approximately 1/10 of the cells printed in 
Matrigel and Pluronic and ~1/2 the cells printed in PBS. Matrigel showed a six-fold 
increase in cell number after one week while the Pluronic has a ten-fold increase, which 
indicates the cells are surviving and proliferating. Surprisingly, the MTT assay exhibited 
a decrease in absorbance, which is equated with percent viability, after one week for all 
bio-inks (Figure 3.22A and 3.22B). This is inconsistent with the results from the 
live/dead analysis that show similar viability from one day to one week (Figure 3.17I and 
3.22J). This could be due to problems when transferring to the 96-well plate but the MTT 
assay does not seem to be a viable option as a high through put assay to analyze the 
composite scaffolds. The composite scaffolds returned unusally high absorbance numbers 
with a high standard deviation that suggest the composite itself interferes with the assay 
(Figure 3.22A and 2.32B). The high standard deviations and odd decrease in absorbance 
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after one week suggest that an additional trial would need to be run to make further 









Figure 3.22 Methods to evaluate bio-printed rBMSCs, (A-B) Viability and (C-D) number  
of rBMSCs (A,C) 1 day and (B,D) 1 week after printing. There was no significant 
difference between the Matrigel and Pluronic. The results are inconsistent for the C3 
composite and indicate the unsuitability of these particular tests when determining 












 Printing parameters for different glass concentrations of a chloroform-dissolved 
PCL/13-93B3 glass composite were established using a modified extrusion printer. 
Scaffolds with no warpage were fabricated using 30-50wt.% glass. Scaffolds exhibited 
bioactivity through a controlled release of bioactive glass in media over two weeks and 
the formation of hydroxyapatite-like crystals on the surface. This demonstrates that 
bioactive glass can be printed without the need to heat up to hundreds of degrees 
centigrade, making it possible to print cells concurrently on the scaffold.    
The effect of chloroform evaporation on cell viability was determined by printing 
droplets of hASCs suspended in Matrigel on a single layer of the composite paste. One 
week after printing and incubating under standard cell culture conditions, more than 60% 
hASCs were shown to be viable. With multi-layer scaffolds, the droplets could not be 
precisely placed such that they did not interfere with printing the next layer of the 
composite. This caused the scaffolds to print inconsistently and fill in the pores which 
indicates that although cells can survive the printing and choice of biomaterials, they 
need to be printed with a different method in order to maintain the integrity of the 
scaffold. 
The ability of cells to be printed in different bio-inks as filaments and not droplets 
was evaluated.  MSCs were suspended in the composite, Matrigel, and Pluronic hydrogel 
then printed in a single layer and incubated under standard cell culture conditions for one 
day and one week. Matrigel and Pluronic had a mix of rBMSCs both suspended and 
exhibiting spreading behavior after one week while PBS only had spreading cells. The 
viability of all the bio-inks after both one day and one week as measured using a 
live/dead assay was over 60%. There was no significant difference between the viability 
of the different bio-inks, which means using the composite as a bio-ink is feasible 
Different sources of MSCs were printed to evaluate the ideal cell type for 
bioprinting. One day after printing, a mixture of hASCs and hBMSCs had a viability of 
over 96% in all bio-inks. The cells suspended in PBS and Pluronic even showed 
directional growth typical of spreading MSCs while the cells suspended in Matrigel 
showed fibroblast-like morphology. This is in comparison to rBMSCs which had over 
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60% viability and fibroblast-like morphology in PBS, Pluronic, and Matrigel. rSVF was 
investigated as a possible source; however, evaluation should not be performed after one 
day.  
In order to determine the best method to measure cellular activity after printing, 
different biological assays were evaluated.  The composite, Matrigel, and Pluronic were 
evaluated at 1 day and 1 week after printing using a MTT assay, CyQuant assay, and a 
Live/Dead stain. The MTT and CyQuant assays were unable to accurately detect cells 
within the composite leaving the Live/Dead stain as the best method to evaluate cell 
numbers and viability. 
Future directions include evaluating different MSC populations on a multiple 
layer scaffold for both viability and differentiation capacity.  Another direction would be 
investigating the use of different polymers and solvents and their uses for applications 
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